Provided by Tiger Trade Technology Pte. Ltd.

Aktis Oncology

18.15
+0.41002.31%
Post-market: 18.150.00000.00%19:30 EDT
Volume:361.04K
Turnover:6.49M
Market Cap:1.00B
PE:-13.27
High:18.21
Open:17.74
Low:17.59
Close:17.74
52wk High:34.19
52wk Low:14.72
Shares:55.28M
Float Shares:17.65M
Volume Ratio:1.06
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3680
EPS(LYR):-78.3394
ROE:-29.45%
ROA:-15.79%
PB:2.07
PE(LYR):-0.23

Loading ...

May 20, 2024

Major Issues Report

Form 8-K - Current report
May 18, 2024

Correspondence

Form CORRESP - Correspondence
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 29, 2024

Major Issues Report

Form 8-K - Current report
Jan 24, 2024

Major Issues Report

Form 8-K - Current report
Dec 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Oct 27, 2023

Major Issues Report

Form 8-K - Current report
Sep 29, 2023

Major Issues Report

Form 8-K - Current report